Ropinirole alters gene expression profiles in SH-SY5Y cells: A whole genome microarray study

M. Z. Zhu, W. D. Le, G. Jin

Research output: Contribution to journalArticlepeer-review


Ropinirole (ROP) is a dopamine agonist that has been used as therapy for Parkinson’s disease. In the present study, we aimed to detect whether gene expression was modulated by ROP in SH-SY5Y cells. SH-SY5Y cell lines were treated with 10 mM ROP for 2 h, after which total RNA was extracted for whole genome analysis. Gene expression profiling revealed that 113 genes were differentially expressed after ROP treatment compared with control cells. Further pathway analysis revealed modulation of the phosphatidylinositol 3-kinase (PI3K) signaling pathway, with prominent upregulation of PIK3C2B. Moreover, batches of regulated genes, including PIK3C2B, were found to be located on chromosome 1. These findings were validated by quantitative RT-PCR and Western blot analysis. Our study, therefore, revealed that ROP altered gene expression in SH-SY5Y cells, and future investigation of PIK3C2B and other loci on chromosome 1 may provide long-term implications for identifying novel target genes of Parkinson’s disease.

Original languageEnglish (US)
Article numbere4857
JournalBrazilian Journal of Medical and Biological Research
Issue number2
StatePublished - 2016


  • Gene expression
  • Parkinson’s disease
  • Ropinirole
  • SH-SY5Y

ASJC Scopus subject areas

  • Biophysics
  • Neuroscience(all)
  • Biochemistry
  • Physiology
  • Immunology
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Cell Biology


Dive into the research topics of 'Ropinirole alters gene expression profiles in SH-SY5Y cells: A whole genome microarray study'. Together they form a unique fingerprint.

Cite this